GERON CORP revenue for the last year amounted to 199.54 k CHF, the most of which — 199.54 k CHF — came from its highest performing source at the moment, Therapeutic Products for Oncology, the year earlier bringing 551.14 k CHF. The greatest contribution to the revenue figure was made by United States — last year it brought GERON CORP 199.54 k CHF, and the year before that — 551.14 k CHF.